Identification and

Pediatric leukemia cancer vaccine high risk T-ALL neoantigen peptide pediatric immunotherapy

Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
02 12 2021
Historique:
pubmed: 1 12 2021
medline: 19 4 2022
entrez: 30 11 2021
Statut: ppublish

Résumé

There is experimental and clinical data to indicate the contribution of immune-escape mechanisms in relapsed/refractory pediatric leukemia. Studies have shown the accumulation of mutations that translate to peptides containing tumor-specific epitopes (neoantigens). The effectiveness of neoantigen-based vaccines has been shown in several clinical trials in adults. Though the initial results are encouraging, this knowledge must be developed to account for the uniqueness of pediatric cancer biology. We have completed the initial proof-of-concept analysis on a high-risk pediatric leukemia specimen and identified usable neoantigen sequences. We describe this approach, including the bioinformatics method and experimental model to verify their function that can be further broadened for personalized neoantigen prediction and testing for the generation of anticancer vaccines against high-risk pediatric leukemias.

Identifiants

pubmed: 34844524
doi: 10.1080/21645515.2021.2001243
pmc: PMC8904024
doi:

Substances chimiques

Antigens, Neoplasm 0
Cancer Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5558-5562

Références

Nat Rev Clin Oncol. 2021 Apr;18(4):215-229
pubmed: 33473220
Nucleic Acids Res. 2001 Jan 1;29(1):308-11
pubmed: 11125122
Nature. 2017 Jul 13;547(7662):217-221
pubmed: 28678778
Nucleic Acids Res. 2017 Jan 4;45(D1):D840-D845
pubmed: 27899611
Nature. 2017 Jul 13;547(7662):222-226
pubmed: 28678784
Cancer Metastasis Rev. 2019 Dec;38(4):573-594
pubmed: 31828566
J Immunol. 2017 Nov 1;199(9):3360-3368
pubmed: 28978689
Nat Rev Cancer. 2014 Feb;14(2):135-46
pubmed: 24457417
Cell. 2017 Nov 16;171(5):1042-1056.e10
pubmed: 29056344
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Nucleic Acids Res. 2017 Jan 4;45(D1):D854-D859
pubmed: 27638885
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Science. 2015 May 15;348(6236):803-8
pubmed: 25837513
Nat Rev Immunol. 2018 Mar;18(3):168-182
pubmed: 29226910
Nature. 2019 Jan;565(7738):240-245
pubmed: 30568303
Cancer Cell. 2017 Apr 10;31(4):476-485
pubmed: 28366678
Clin Cancer Res. 2020 Sep 1;26(17):4511-4520
pubmed: 32439700
Sci Rep. 2018 Aug 14;8(1):12122
pubmed: 30108227
Genome Med. 2017 Aug 31;9(1):78
pubmed: 28854978

Auteurs

Satbir Thakur (S)

Division of Pediatric Oncology, Alberta Children's Hospital, Calgary, Alberta, Canada.

Mohit Jain (M)

Division of Pediatric Oncology, Alberta Children's Hospital, Calgary, Alberta, Canada.

Chunfen Zhang (C)

Division of Pediatric Oncology, Alberta Children's Hospital, Calgary, Alberta, Canada.

Candice Major (C)

Division of Pediatric Oncology, Alberta Children's Hospital, Calgary, Alberta, Canada.

Kevin J Bielamowicz (KJ)

Division of Hematology/Oncology, Arkansas Children's Hospital, Little Rock, Arkansas.

Norman J Lacayo (NJ)

Department of Oncology, Stanford University School of Medicine, Stanford, California.

Olena Vaske (O)

Department of Molecular, Cell and Developmental Biology, University of California Santa Cruz, Santa Cruz, California.

Victor Lewis (V)

Division of Pediatric Oncology, Alberta Children's Hospital, Calgary, Alberta, Canada.

Luis Murguia-Favela (L)

Section of Hematology and Immunology, Alberta Children's Hospital, University of Calgary, Calgary, Alberta, Canada.

Aru Narendran (A)

Division of Pediatric Oncology, Alberta Children's Hospital, Calgary, Alberta, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH